bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Akebia Therapeutics Inc. logo

    Akebia Therapeutics Inc.

    AKBA | NASDAQ
    Chart Builder DCF Calculator
    $0.94
    +$0.02 (+2.65%)
    At close: Sep 21, 2026, 4:00 PM ET
    $0.95
    +$0.01 (+0.74%)
    Pre-market: Sep 22, 2026, 9:22 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $251.76M
    Enterprise Value
    $150.18M
    Beta
    0.24
    Average Volume
    5.86M
    Shares Outstanding (Diluted)
    269.6M
    Shares Change YoY
    -0.55%
    Institutional Ownership
    38.08%
    Exchange
    NASDAQ
    ISIN
    US00972D1054

    Price Performance

    Price Change 1M
    3.3%
    Price Change 3M
    -14.6%
    Price Change 6M
    -32.4%
    Price Change YTD
    -39.4%
    Price Change 1Y
    -66.3%
    Price Change 3Y
    -20.3%
    Price Change 5Y
    -67.1%
    1M CAGR (ann.)
    3.1%
    1Y CAGR (ann.)
    -68.3%
    5Y CAGR (ann.)
    -20.3%
    All-Time CAGR
    -23.5%

    Valuation

    PE Ratio
    -8.55
    Forward PE
    15.33
    PEG Ratio
    0.02
    Forward PEG
    -0.07
    PS Ratio
    1.15
    Forward PS
    1.90
    PB Ratio
    10.06
    P/FCF Ratio
    6.26
    P/Adj. FCF Ratio
    9.35
    P/OCF Ratio
    6.27
    EV/Sales
    0.69
    EV/EBIT
    -7.55
    EV/EBITDA
    -8.34
    EV/FCF
    3.73
    Earnings Yield
    -11.7%
    FCF Yield
    16.0%
    Adj. FCF Yield
    10.7%

    Financial Health

    Net Cash
    $105.99M
    Total Debt
    $53.96M
    Cash & Short-Term Investments
    $155.55M
    Total Assets
    $349.66M
    Current Ratio
    1.43
    Quick Ratio
    1.35
    Debt / Equity Ratio
    2.16
    Debt / EBITDA
    -3.00
    Debt / FCF
    1.34
    OCF / Debt
    0.77
    Interest Coverage
    -1.90
    Altman Z-Score
    -5.67
    Piotroski F-Score
    6

    Margins & Profitability

    Gross Profit Margin
    79.5%
    Operating Profit Margin
    -6.9%
    EBITDA Margin
    -8.2%
    Net Profit Margin
    -13.5%
    FCF Margin
    18.4%
    Adj. FCF Margin
    12.3%
    SBC / Revenue
    6.1%
    SBC Impact (per share)
    -33.1%

    Returns

    Return on Assets
    -8.5%
    Return on Equity
    -93.7%
    Return on Invested Capital
    -7.1%
    Return on Capital Employed
    -8.0%
    Return on Tangible Assets
    -10.2%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    3.0%
    Revenue CAGR 5Y
    -0.3%
    Revenue CAGR 10Y
    1.3%
    EPS CAGR 3Y
    28.1%
    EPS CAGR 5Y
    51.8%
    EPS CAGR 10Y
    25.2%
    FCF CAGR 3Y
    9010.9%
    FCF CAGR 5Y
    109.8%
    FCF CAGR 10Y
    12.6%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    12
    EPS Growth Next 3Y
    6.1%
    Revenue Growth Next 3Y
    -3.4%
    Earnings Date
    Nov 8, 2026
    EPS Estimate (next Q)
    -$0.03
    EPS Growth Est (next Q)
    -1622.8%
    Revenue Est (next Q)
    $46.94M
    Revenue Growth Est (next Q)
    -20.1%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $1
    Price Target Upside
    6.4%

    Cash Flow

    Operating Cash Flow
    $41.55M
    Free Cash Flow
    $40.23M
    Adj. Free Cash Flow
    $26.92M
    FCF Per Share
    $0.15
    OCF Per Share
    $0.15
    OCF/S Ratio
    19.0%

    Income Statement

    Revenue
    $219.06M
    Gross Profit
    $174.1M
    Operating Income
    $-15.13M
    EBITDA
    $-18.01M
    Net Income
    $-29.67M
    EPS (Diluted)
    -$0.11
    Revenue / Employee
    $1.13M
    Profit / Employee
    $-152.92K
    Employees
    194

    © 2026 bestshares.com. All rights reserved.